Vaccines

The COVID-19 response illustrates steps officials should take to ensure the effectiveness of vaccine mandates.

Scholar argues that generational amnesia may lead to ineffective regulatory solutions in the future.

Experts discuss FDA’s COVID-19 emergency authorizations and how to recalibrate the regulatory mechanism.

In rejecting agency action on the basis of the “major questions doctrine,” judges undermine congressional policies.

Another regulatory approach to mandate vaccines could have withstood judicial scrutiny.

The Biden Administration should exert international and domestic pressure to waive COVID-19 vaccine patents.

Advocates say a vaccine mandate for domestic flights could help keep travelers safe.

Scholars discuss the challenges of promoting antibiotic development and preserving existing drugs.

The structure of some essential oils companies makes it harder for federal agencies to restrain false claims.

Scholar claims that regulatory sandboxes such as emergency use authorizations boost innovation, but at a cost.

Contrary to longstanding precedent, individualism reigns supreme in recent legal decisions over COVID-19.

The collaboration between pharmaceutical giants puts antitrust law at risk.